Octadecanoic acid dissolved in the solution accounts for at least 0.67% but not more than 1.0% of the surface composition. Molecular weight of mucus between 300 and 500, polyethylene, hydroxyethyl-cyclopentanediol, hydroxypropyl alcohol? - Cyclopentanediol or its compounds and chlorobenzene； gout containing ophthalmic compounds； gout used in the treatment of conjunctivitis.
GAMACHE, DANIEL A.,ALANI, LAMAN,GHOS, MALAY,GALAN, FRANCISCO JAVIER,PERDIGUER, NURIA,SINGH, ONKAR
申请号：
CL2013002467
公开号：
CL2013002467A1
申请日:
2013.08.27
申请国别(地区):
CL
年份:
2014
代理人:
摘要：
The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution. The composition is preferably capable of providing enhanced relief from symptoms of ocular allergic conjunctivitis, particularly late phase symptoms of ocular allergic conjunctivitis.COMPOSICIÓN OFTÁLMICA QUE COMPRENDE AL MENOS 0,67% PERO NO MÁS DE 1,0% P/V DE OLOPATADINA DISUELTA EN SOLUCION, PEG CON UN PESO MOLECULAR DE 300 A 500, POLIVINILPIRROLIDONA, HIDROXIALQUIL ß-CICLODEXTRINA, HIDROXIALQUIL ?-CICLODEXTRINA O SU COMBINACIÓN Y CLORURO DE BENZALCONIO； GOTARIO QUE COMPRENDE A LA COMPOSICIÓN OFTÁLMICA； Y SU USO EN EL TRATAMIENTO DE LA CONJUNTIVITIS ALÉRGICA OCULAR.
